Results 211 to 220 of about 29,030 (239)

Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial

Lancet Neurology, The, 2017
Joan Montaner, S Claiborne Johnston, Aneesh B Singhal   +2 more
exaly   +2 more sources

Natalizumab

Reactions Weekly, 2015
  +8 more sources

Natalizumab

Reactions Weekly, 2016
  +7 more sources

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

Neurological Sciences, 2023
C. Boz, S. Ozakbas, M. Terzi, R. Karabudak, S. Sevim, R. Turkoglu, A. Soysal, B. P. Balci, H. Efendı, Ö. F. Turan, Nur Yüceyar, M. Yetkin, S. Z. Karahan, M. Demirkıran, S. Guler, K. Ağan, N. Kıylıoğlu, C. Baba, A. Tuncer, Mesrure Köseoğlu   +19 more
semanticscholar   +1 more source

Natalizumab

Reactions Weekly, 2021
openaire   +2 more sources

Natalizumab

Reactions Weekly, 2017
  +6 more sources

Natalizumab

Reactions Weekly, 2022
openaire   +2 more sources

Natalizumab

Reactions Weekly, 2013
  +6 more sources

Natalizumab

Reactions Weekly, 2014
  +4 more sources

Natalizumab

Reactions Weekly, 2011
  +5 more sources